TruScreen Annual Report and Section 209C Notice

31 July 2018 NZX Announcement TRUSCREEN LIMITED: Annual Report and Section 209C Notice TruScreen Limited (NZX: TRU) has released its Annual Report for the year ended 31 March 2018. This can be viewed at http://truscreen.com/investor-centre/reports-presentations/. Please find attached the following documents: o Annual Report 2018 o Chairman's Letter to Shareholders o Section 209C notice ENDS For more information visit www.truscreen.com or contact: Martin Dillon TruScreen Chief Executive Officer Email: martindillon@truscreen.com About TruScreen: TruScreen's real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection. End CA:00321518 For:TRU Type:ANNREP Time:2018-07-31 15:10:17